Cryoport (MM) (NASDAQ:CYPT)
Historical Stock Chart
From May 2019 to May 2024
Marr Technologies Clarifies Ownership Position in Calypte Biomedical
Member of the Marr Group Acquired a Total of 5.4 Million Shares Through Open
Market Purchase of Stock bringing total Calypte holdings to 38,915,151
LONDON, Nov. 3 /PRNewswire-FirstCall/ -- Marr Technologies Limited, a member of
the Marr Group, clarified its ownership position in Calypte Biomedical
(BULLETIN BOARD: CYPT) today. According to a recent filing, the investment
group owns 38,915,151 shares of Calypte's common stock. It acquired 33,515,151
of these shares directly from the company through private placements comprising
two subscriptions for 8,333,333 and 20,000,000 shares respectively and
conversion of a debenture for 5,181,818 shares. In addition, the company has
acquired 5.4 million shares via open market purchases. The purchase prices for
the shares acquired in the open market ranged from $0.1225 to $1.31.
"We remain highly confident in Calypte's HIV screening technology," said Marat
Safin, President of Marr Technologies Limited. "This is why we elected to
increase our already sizable investment in the company though open market
purchases. Unfortunately, there has been some misinformation and
misinterpretation about the way these shares were acquired. The 5.2 million
shares, which were referred to in a press release Calypte issued on October 2,
2003 were acquired through open market purchases, and not via private sales or
convertible financing structures. We hope our coming forward will allow
investors to focus on the potential for the company's technology."
About Marr Technologies Limited
Marr Technologies Limited is a member of the Marr Group of companies (the
"Group"). The Group is a private group controlled by the Safin family and
administered from London. Marat Safin, a London School of Economics graduate, is
the President of the Group. The Group has a large and diverse number of
investments and projects globally, principally in Europe, the Far East, the
Middle East and the CIS, with substantial investments in telecoms and technology
projects.
CONTACT: Andy D Brown, Advisor to the Marr Group;
011-44-207627-9898
DATASOURCE: Marr Technologies Limited
CONTACT: Andy D Brown, Advisor to the Marr Group, +011-44-207627-9898,